Last quarter (Q4 2022), GlaxoSmithKline's total revenue was £7.38B, a decrease of -22.58% from the same quarter last year. In Q4, GlaxoSmithKline's net income was £1.46B. See GlaxoSmithKline’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	£ 31.91B	£ 30.33B	£ 29.32B	£ 34.11B	£ 34.10B	£ 33.75B
Cost of Revenue	£ 10.53B	£ 8.56B	£ 9.55B	£ 11.60B	£ 11.70B	£ 11.86B
Gross Profit	£ 21.39B	£ 21.76B	£ 19.77B	£ 22.51B	£ 22.39B	£ 21.89B
Operating Expense	£ 14.15B	£ 14.13B	£ 14.64B	£ 15.83B	£ 16.17B	£ 15.60B
Operating Income	£ 7.24B	£ 7.63B	£ 5.13B	£ 6.68B	£ 6.22B	£ 6.29B
Net Non Operating Interest Income Expense	£ -830.00M	£ -785.00M	£ -831.00M	£ 754.00M	£ -850.00M	£ -840.00M
Other Income Expense	-	£ 308.00M	£ -1.33B	-	-	-
Pretax Income	£ 6.13B	£ 6.06B	£ 5.63B	£ 5.44B	£ 6.97B	£ 6.22B
Tax Provision	£ 815.00M	£ 756.00M	£ 707.00M	£ 346.00M	£ 580.00M	£ 953.00M
Earnings From Equity Interest Net Of Tax	-	£ -5.00M	£ -2.00M	-	-	-
Net Income Common Stockholders	£ 14.45B	£ 4.93B	£ 14.96B	£ 4.38B	£ 5.75B	£ 4.64B
Basic EPS	£ 3.59	£ 1.22	£ 3.72	£ 1.38	£ 1.16	£ 0.94
Diluted EPS	£ 3.54	£ 1.20	£ 3.66	£ 1.35	£ 1.14	£ 0.93
Basic Average Shares	£ 16.10B	£ 4.05B	£ 4.03B	£ 3.20B	£ 4.98B	£ 4.95B
Diluted Average Shares	£ 16.30B	£ 4.11B	£ 4.08B	£ 3.24B	£ 5.04B	£ 5.02B
Dividend Per Share	£ 0.76	£ 0.58	£ 0.61	£ 1.25	£ 0.80	£ 0.80
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	£ 1.57	-	-	-	£ 1.16	£ 1.24
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	£ 27.00M	£ 29.00M
Total Expenses	£ 24.68B	£ 22.69B	£ 24.19B	£ -27.43B	£ 27.88B	£ 27.46B
Net Income From Continuing And Discontinued Operation	£ 14.45B	£ 4.93B	£ 14.96B	£ 4.38B	£ 5.75B	£ 4.64B
Normalized Income	£ 4.42B	£ 5.75B	£ 4.34B	£ 4.31B	£ 4.32B	£ 4.06B
Interest Expense	£ 833.00M	-	-	-	£ 856.00M	£ 879.00M
EBIT	£ 6.96B	£ 6.87B	£ 6.46B	£ 6.22B	£ 7.82B	£ 7.10B
EBITDA	£ 9.26B	£ 9.16B	£ 8.61B	£ 6.22B	£ 10.18B	£ 9.43B

Currency in GBP

GlaxoSmithKline Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing